[ad_1] Biogen Inc. and Eisai Co. late Wednesday released new data on their Alzheimer’s treatment…
Tag:
Eisai Co. Ltd.
-
-
STOCK MARKET
Merck and Eisai say two lung-cancer trials failed to meet their main goals
by userby user[ad_1] Merck and Japanese partner Eisai said Friday that two late-stage trials of a treatment…
-
STOCK MARKET
FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
by userby user[ad_1] The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen…
-
STOCK MARKET
FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment
by userby user[ad_1] Advisers to the U.S. Food and Drug Administration on Friday voted unanimously in favor…
-
STOCK MARKET
Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
by userby user[ad_1] Eisai shares 4523, +8.77% rose sharply Thursday morning after the U.S. Food and Drug…
-
STOCK MARKET
5 things to know about the new Alzheimer’s drug — including why it may be risky for people who take blood thinners
by userby user[ad_1] Shares of Eisai and Biogen did not move dramatically after the drug companies reported…
-
STOCK MARKET
A new Alzheimer’s treatment may help some patients, though researchers say more safety data is needed
by userby user[ad_1] A new study found that Eisai and Biogen’s experimental Alzheimer’s drug moderately reduced cognitive…
-
STOCK MARKET
Eisai shares fall following report of patient death in Alzheimer’s trial
by userby user[ad_1] Eisai Co.’s shares fell Tuesday following a report that a woman died after receiving…
-
[ad_1] Eisai 4523, +1.23% plans to share additional data about the Alzheimer’s disease treatment it’s…
-
STOCK MARKET
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
by userby user[ad_1] Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker…
- 1
- 2